Periodontitis Clinical Trials

Find Periodontitis Clinical Trials Near You

The Role of Biochemical and Microbiological Properties of Granulation Tissue in Periodontal Regeneration

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this observational study is to distinguish the infectious, healing, and regeneration-related characteristics of two types of gingival granulation tissues, namely infra-osseous and supra-osseous granulation tissues, in people with severe periodontitis (gum disease). Researchers aim to denote if these tissues may play role in healing after periodontal treatment. Researchers will also compare smokers and non-smokers to see if smoking disrupts the healing potential or infectious properties of granulation tissue. Participants will provide gingival fluid (before) and granulation tissue samples (at the time of) periodontal surgery. The main questions this study aims to answer are: 1. Do infra- and supra-osseous granulation tissues have different healing potential and infectious properties? 2. How do these tissues differ in people who smoke compared to people who do not smoke?

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Both genders.

• Systemically healthy.

• Both smokers (smoking at least 10 cigarettes a day or electronic cigarettes daily or quit less than 5 years ago) and non-smokers (never smoked, smoke no more than once a month or quit at least 5 years ago).

• Patients aged 18 years and over.

• Patients with a history of severe periodontitis (stage III or IV, grade B-C) and, after completion of the non-surgical stage of periodontal treatment with at least one residual vertical bone defects (with ≥3 mm infrabony component) in premolar-molar region.

• Patients with a plaque index and bleeding on probing of 20% or lower before surgery.

Locations
Other Locations
Latvia
Riga Stradins University Institute of Stomatology
RECRUITING
Riga
Contact Information
Primary
Dārta E Emuliņa, DDS
dartaemulina@gmail.com
+37122007988
Time Frame
Start Date: 2025-05-29
Estimated Completion Date: 2026-09
Participants
Target number of participants: 46
Treatments
Non-smoking periodontitis patients
Non-smoking Stage III-IV Grade B-C periodontitis patients with at least one infra-osseous approximal bone defect (with ≥3 mm infrabony component) at premolar-molar region (n=23).
Smoking periodontitis patients
Smoking Stage III-IV Grade B-C periodontitis patients with at least one infra-osseous approximal bone defect (with ≥3 mm infrabony component) at premolar-molar region (n=23).
Related Therapeutic Areas
Sponsors
Collaborators: University of Turku
Leads: Riga Stradins University

This content was sourced from clinicaltrials.gov